Glenmark Pharmaceuticals Cash Flow Annual

Trade
BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035 | Sector: Biotechnology & Drugs
1,493.45 +13.40 (0.91%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 569.19868.451,441.251,382.48
Depreciation/ Depletion 630.81611.27486.72443.55
Non- Cash Items 379.00860.70300.39201.26
Changesin Working Capital -2,036.20-1,714.35-1,119.70-896.08
Cashfrom Operating Activities -457.20626.061,108.651,131.21
Capital Expenditures -914.88-607.76-790.12-774.76
Other Investing Cash Flow Items Total 5,475.7779.27456.8499.52
Cashfrom Investing Activities 4,560.89-528.49-333.28-675.24
Financing Cash Flow Items -516.78-464.27-307.90-293.62
Total Cash Dividends Paid -117.75-136.61-92.70-70.45
Issuance( Retirement)of Stock Net 1.200.001,011.85-
Issuance( Retirement)of Debt Net -3,272.79523.42-1,131.75-77.71
Cashfrom Financing Activities -3,906.13-77.46-520.49-441.78
Foreign Exchange Effects 17.6812.3917.5513.62
Net Changein Cash 215.2432.50272.4327.82
Cash Interest Paid 516.78311.54250.51293.62
Cash Taxes Paid 1,047.49640.54558.44510.24
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts